Home
Board of Directors
Membership
Apply for INA Membership
Account Details
TOXINS 2026
PRECEPTORSHIP
FAQs
Previous Congresses
TOXINS 2024
TOXINS 2022
TOXINS 2021 Virtual
TOXINS 2019
General Information
Organizing Committee
Speakers
Conference Program
EACCME Statement
TOXINS 101 Workshop
Hands-on Ultrasound Guidance Workshop
Topics to be Addressed
Sponsors
Venue & Housing Information
Registration Information
Satellite Symposia
TOXINS 2019 Registration (closed)
Abstract Submission (closed)
Poster Presentation Details
Sponsorship/Exhibitor Opportunities
Copenhagen Travel
TOXINS 2017
General Information
Organizing Committee
Conference Program
EACCME Statement
Venue & Housing Information
Registration Information
Satellite Symposia
TOXINS 2017 Registration (closed)
Abstract Submission (closed)
Exhibitor Opportunities
Sponsors
TOXINS 2015
General Information
Organizing Committee
Conference Program
CME/CPD Information
Venue & Housing Information
Satellite Symposia
Registration Information
TOXINS 2015 Registration (closed)
Abstract Submission (closed)
Exhibitor Opportunities
TAP Portugal Airline
Sponsors
TOXINS 2012
General Information
Conference Program
CME/CPD Information
Calendar
About
Contact
TOXINS 2024 Post-Conference Survey
Name Badge ID
(Required)
Full Name
(Required)
Dr.
Miss
Mr.
Mrs.
Ms.
Prof.
Rev.
Prefix
First
Last
Email
(Required)
INA Username
If you are an INA Member, please enter your username below.
Gender
(Required)
Male
Female
Other
Choose not to specify
Degree
(Required)
MD
DO
MB
MD, PhD
DO, PhD
PhD
DDS
NP
PA
RN
Other
Country of Origin
(Required)
Select...
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos Islands
Colombia
Comoros
Congo, Democratic Republic of the
Congo, Republic of the
Cook Islands
Costa Rica
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Côte d'Ivoire
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Eswatini (Swaziland)
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard and McDonald Islands
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestine, State of
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Romania
Russia
Rwanda
Réunion
Saint Barthélemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
US Minor Outlying Islands
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Åland Islands
What is your professional status?
(Required)
Physician
Scientist
Physician Assistant
Nurse
Pharmaceutical/Device Company Employee/Representative
Non-Profit Organization Representative
Student
Other
Please specify your professional status
(Required)
What is your specialty focus?
(Required)
Select...
Aesthetic Medicine
Basic Science
Dermatology
Gastroenterolgy
General Surgery
Internal Medicine
Microbiology
Neurobiology
Neurochemistry
Neurology
Neurosurgery
Obstetrics/Gynecology
Occupational Therapy
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pediatrics
Physicial Medicine & Rehabilitation
Physical Therapy
Speech-Language Pathology
Urology
Other
Please specify your specialty focus
(Required)
Type of Practice:
(Required)
Select...
Academic Institution
Hospital Setting
Research Laboratory/Facility
Private Practice
Rehabilitation Facility
Other
Please specify type of practice
(Required)
Number of years in practice/research:
(Required)
Select...
<1
1-5
6-10
11-20
21-30
31-40
>40
Self-Assessment
How did this conference affect your ability to:
(A) Review the mechanisms of action and pharmacology of various botulinum neurotoxin serotypes and preparations, in order to understand their therapeutic effect
Major Improvement
Some Improvement
No Difference
My Ability Declined
N/A
(B) Evaluate clinical data, evidence-based recommendations, and practical experience in the use of botulinum neurotoxins for multiple and diverse clinical conditions, to properly assess and select appropriate patients for neurotoxin therapy
Major Improvement
Some Improvement
No Difference
My Ability Declined
N/A
(C) Demonstrate best practice procedures and techniques for neurotoxin injections, to improve clinical skills and optimize patient outcomes
Major Improvement
Some Improvement
No Difference
My Ability Declined
N/A
(D) Promote interaction and cooperation among a wide range of scientific and clinical disciplines, to advance research and education relevant to the science and therapeutic application of botulinum and other neurotoxins
Major Improvement
Some Improvement
No Difference
My Ability Declined
N/A
Which of the above learning objectives is most important to you?
(Required)
A
B
C
D
Did you achieve the learning goals you identified for yourself at the beginning of the conference?
(Required)
Yes
No
What is the most important thing you learned at this conference?
(Required)
Was the presented information well balanced and consistently supported by a valid scientific evidence base?
(Required)
Very much
Somewhat
Not much
Not at all
Undecided
The knowledge or skills gained from the conference can be applied to my work
(Required)
Yes
No
As a result of this conference, I will likely change my practice in the following areas: (Check all areas that apply)
Patient evaluation
Clinical assessment
Selection of optimal therapeutic options(s)
Dosing and administration of botulinum neurotoxins
Localization of neurotoxin injections
Documentation of patient outcomes
Other
N/A
Please specify other clinical area
(Required)
I will make the following specific change in my practice
Ability to evaluate the latest clinical and scientific research into botulinum neurotoxins
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
N/A
Understanding of the clinical utility of botulinum neurotoxins
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
N/A
Understanding of potential new therapeutic applications of botulinum neurotoxins
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
N/A
Biomedical knowledge of botulinum and other neurotoxins and their application in enhancing therapeutics and improving care
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
N/A
As a result of this conference, I will likely change my research in the following areas: (Check all areas that apply)
Research methodology
Focus and/or direction of research
Translation of research to therapeutic applications
Other
N/A
Please evaluate this activity (TOXINS 2024) as a whole
Overall Evaluation
(Required)
Excellent
Good
Fair
Poor
Program content
Relevance to my clinical practice/research
Effectiveness in meeting identified need
Overall, I would rate TOXINS 2024 as
(Required)
Excellent
Good
Fair
Poor
Was there adequate time available for discussions, questions and answers and learner engagement?
(Required)
Yes, always/almost always
Yes, sometimes
Only rarely
Never
Undecided
Did all the faculty members provide their potential conflict of interest declaration with the sponsor(s) as a second slide of their presentation?
(Required)
Yes, all
Yes, for the majority
Yes, but only a small part
No
Undecided/don't know
What was the most effective aspect(s) of this conference and why?
What was the least effective aspect(s) of this conference?
What topics, if any still remain unclear to you?
Suggestions for any specific lectures/topics that you would like covered at future TOXINS Conferences
Were the sessions fair balanced and free of commercial bias?
(Required)
Yes
No
If you answered "No", please explain your reason(s)
Additional comments
Member Login
Username
(Required)
Password
(Required)
Remember Me
Not a member
Forgot Password?
TOXINS 2024
Abstract Submission (closed)
Conference Program
EACCME Information
Frequently Asked Questions
General Information
Industry Activities
Letter From the Chairs
Organizing Committee
Poster Presentation Details
Schedule of Events
Shipping, Storage, and Exhibitor’s Catalogue
Speakers
Sponsors
Sponsorship/Exhibitor Opportunities
Topics of Discussion
Registration Information
TOXINS 2024 Abstract Winners
TOXINS 2024 Registration (closed)
TOXINS 2024 Virtual Poster Hall
Venue & Housing Information
Join Our Mailing List
Click here
to sign up, and then manage your subscription.